Osteoarthritis Clinical Trial
Official title:
A PHASE 3, MULTICENTER, LONG-TERM OBSERVATIONAL STUDY OF SUBJECTS FROM TANEZUMAB STUDIES WHO UNDERGO A TOTAL KNEE, HIP OR SHOULDER REPLACEMENT
Verified date | July 2020 |
Source | Pfizer |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A4091064 is a multicenter, long-term observational study of subjects from tanezumab interventional studies (regardless of treatment group) who undergo a total knee, hip or shoulder replacement during participation in the study. The study is designed with a total duration of subject follow-up of 24 weeks after the total joint replacement surgery. There will be two methods of data collection utilized in this study: interview by site staff via the telephone and interactive web-response system (or paper if the subject has no access to the internet).
Status | Completed |
Enrollment | 154 |
Est. completion date | July 15, 2019 |
Est. primary completion date | July 15, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Personally signed and dated informed consent document. - Randomized and treated with subcutaneous investigational product in a tanezumab study and has completed the study or been withdrawn from the study. - Actual or planned total knee, hip or shoulder replacement surgery during the tanezumab study. - Willing and able to comply with scheduled visits and other study procedures. Exclusion Criteria: - None. |
Country | Name | City | State |
---|---|---|---|
Australia | CMAX Clinical Research Pty Ltd | Adelaide | South Australia |
Canada | Dawson Road Medical Centre | Guelph | Ontario |
Canada | Rebecca Medical Associates | Oakville | Ontario |
Canada | Centre de recherche Saint-Louis | Quebec | |
Canada | Recherche Clinique Sigma inc | Quebec | |
Germany | Rheumazentrum Prof. Dr. med Gunther Neeck | Bad Doberan | |
Hungary | Tolna Megyei Balassa Janos Korhaz, Ortopediai Osztaly | Szekszard | |
Italy | Azienda Ospedaliero-Universitaria E Policlinico Umberto I | Rome | |
Japan | Omuro Orthopedic Clinic | Himeji | Hyogo |
Japan | National Hospital Organization Osaka Minami Medical Center | Kawachinagano | Osaka |
Japan | Marunouchi Hospital | Matsumoto | Nagano |
Japan | Nakajo Orthopedic Clinic | Sendai | Miyagi |
Japan | Osaka University Hospital | Suita | Osaka |
Lithuania | Saules seimos medicinos centras | Kaunas | |
New Zealand | South Pacific Clinical Trials | Auckland | |
New Zealand | Southern Clinical Trials- Waitemata Ltd | Auckland | |
New Zealand | Star Unit, North Shore Hospital, Waitemata District Health Board | Auckland | |
New Zealand | Clinical Horizons NZ Ltd | Tauranga | |
Portugal | Hospital Conde de Bertiandos | Ponte de Lima | Viana DO Castelo |
Russian Federation | Medical Technologies Ltd. | Saint-Petersburg | |
Serbia | Institute of Rheumatology | Belgrade | |
Slovakia | Kompan, s.r.o. | Dolny Kubin | |
Slovakia | Slovak Research Center Team Member, MUDr. Viliam Cibik, PhD, s.r.o. | Pruske | |
Spain | Instituto de Ciencias Medicas | Alicante | |
Spain | Hospital del Mar | Barcelona | |
Sweden | Ladulaas Kliniska Studier | Boras, Sweden | |
Sweden | ProbarE I Lund AB | Lund | |
Sweden | ProbarE i Stockholm AB | Stockholm | |
United States | Advanced Research Center, Inc. | Anaheim | California |
United States | JEM Research Institute | Atlantis | Florida |
United States | Masters of Clinical Research, Inc. | Augusta | Georgia |
United States | Great Lakes Research Group, Incorporated | Bay City | Michigan |
United States | Northwest Clinical Research Center | Bellevue | Washington |
United States | Alabama Clinical Therapeutics, LLC | Birmingham | Alabama |
United States | Alabama Orthopaedic Surgeons | Birmingham | Alabama |
United States | Cahaba Research Inc. | Birmingham | Alabama |
United States | Central Alabama Research | Birmingham | Alabama |
United States | Injury Care Research | Boise | Idaho |
United States | Orthopedic Research Institute | Boynton Beach | Florida |
United States | Hope Clinical Research | Canoga Park | California |
United States | Chicago Clinical Research Institute, Inc. | Chicago | Illinois |
United States | Northwestern University | Chicago | Illinois |
United States | Orthopaedic Associates of West Florida | Clearwater | Florida |
United States | Optimed Research LTD | Columbus | Ohio |
United States | Remington-Davis, Incorporated | Columbus | Ohio |
United States | Spectrum Medical, Inc. | Danville | Virginia |
United States | Orthopaedic Associates of Michigan, PC | Grand Rapids | Michigan |
United States | Drug Trials America | Hartsdale | New York |
United States | Abigail R. Neiman, MD, PA | Houston | Texas |
United States | Advances In Health | Houston | Texas |
United States | BI Research Center | Houston | Texas |
United States | Mercury Clinical Research, Inc. | Houston | Texas |
United States | Marvel Clinical Research, LLC | Huntington Beach | California |
United States | Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida |
United States | Physician Research Collaboration, LLC | Lincoln | Nebraska |
United States | Baptist Health Center for Clinical Research | Little Rock | Arkansas |
United States | Clintex Research Group | Miami | Florida |
United States | Best Clinical Trials, LLC | New Orleans | Louisiana |
United States | George Stanley Walker, MD | New Orleans | Louisiana |
United States | American Family Medical | Ocala | Florida |
United States | Renstar Medical Research | Ocala | Florida |
United States | Sunshine Research Center | Opa-locka | Florida |
United States | Advances in Medicine | Palm Desert | California |
United States | Founders Research Corporation | Philadelphia | Pennsylvania |
United States | ClinRx Research | Richardson | Texas |
United States | Clinical Trials Research | Sacramento | California |
United States | DCT - Stone Oak, LLC dba Discovery Clinical Trials | San Antonio | Texas |
United States | California Research Foundation | San Diego | California |
United States | CITrials | Santa Ana | California |
United States | Gulfcoast Research Institute, LLC | Sarasota | Florida |
United States | Kennedy White Orthopaedic Center | Sarasota | Florida |
United States | Stamford Therapeutics Consortium | Stamford | Connecticut |
United States | Stedman Clinical Trials | Tampa | Florida |
United States | AC Clinical Research | Tiffin | Ohio |
United States | Noble Clinical Research | Tucson | Arizona |
United States | Mercury Clinical Research | Webster | Texas |
United States | Professional Research Network of Kansas, LLC | Wichita | Kansas |
United States | North Georgia Clinical Research | Woodstock | Georgia |
United States | North Georgia Internal Medicine | Woodstock | Georgia |
Lead Sponsor | Collaborator |
---|---|
Pfizer | Eli Lilly and Company |
United States, Australia, Canada, Germany, Hungary, Italy, Japan, Lithuania, New Zealand, Portugal, Russian Federation, Serbia, Slovakia, Spain, Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants With Surgeon's Assessment of Procedural Difficulty | Following the TJR surgery on Day 1, the orthopedic surgeon was asked to answer the following question: "taking into consideration the participant's medical history and physical condition prior to surgery would you classify the operative procedure as Uneventful, Minor complications or Major complications." Participants were reported based on these categories for knee, hip and shoulder joint. Participants may have been counted more than once if they had TJR surgery in more than one joint. | Day 1 | |
Primary | Number of Participants With Overall Satisfaction With Surgery as Assessed by the Self-Administered Patient Satisfaction (SAPS) Scale at Week 24 | SAPS contained four questions; How satisfied are you with the 1) results of your surgery 2) results of surgery for improving pain 3) results of surgery for improving ability to do home or yard work, and 4) results of surgery for improving your ability to do recreational activities. Items scored on a 4-point Likert scale with response of 'very satisfied' (100 points), 'somewhat satisfied' (75 points), 'somewhat dissatisfied' (50 points), and 'very dissatisfied' (25 points). The scale score calculated as mean of the scores of individual items, ranging from 25 to 100, with higher scores indicating greater satisfaction. Here, number of participants are summarized as, satisfied (very satisfied and somewhat satisfied categories combined) and dissatisfied (somewhat dissatisfied and very dissatisfied categories combined). Participants may have been counted more than once if they had TJR surgery in more than one joint. | Week 24 | |
Primary | Number of Participants With Post-Surgical Complications Upto Week 24 | Post-surgical complications are adverse events occurring after TJR surgery that were considered clinically significant as assessed by investigator and attributable to the total joint replacement procedure. Participants may have been counted more than once if they had TJR surgery in more than one joint. | Baseline up to Week 24 | |
Primary | Number of Participants With Additional or Corrective Procedures Related to Total Joint Replacement Upto Week 24 | Participants were asked whether they had been told by their orthopedic surgeon that additional or corrective procedures were necessary for their total joint replacement. Participants, who responded as yes have been reported here. Participants may have been counted more than once if they had TJR surgery in more than one joint. | Baseline up to Week 24 | |
Primary | Number of Participants Who Participated in Physical Rehabilitation Activities Related to Total Joint Replacement Upto Week 24 | Participants responded with a yes or no to the following question ''are you participating in physical rehabilitation activities related to your replaced joint''. Participants responded with a yes, have been reported here. Participants may have been counted more than once if they had TJR surgery in more than one joint. | Baseline up to Week 24 | |
Primary | Change From Baseline in Average Pain Score in to be Replaced or Replaced Joints at Week 24 | Participants assessed their average pain in to be replaced (pre-surgery) knee/ hip joint or in the replaced joint (post-surgery) in the past 24 hours using an 11-point numerical rating scale (NRS), ranging from 0 (no pain) to 10 (worst possible pain). Higher scores indicated higher pain. Change from baseline was calculated using the difference between post-baseline weekly mean and the baseline mean score. Participants may have been counted more than once if they had TJR surgery in more than one joint. | Baseline, Week 24 | |
Primary | Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale at Week 24 | WOMAC: Self-administered, disease-specific questionnaire, which assesses clinically important, participant-relevant symptoms for pain, stiffness and physical function in participants with osteoarthritis (OA). The WOMAC pain subscale is a 5-item questionnaire used to assess the amount of pain experienced due to OA of to be replaced/replaced index joint (knee or hip) during past 48 hours. It was calculated as the mean of scores from 5 individual questions. Scores for each question and WOMAC Pain subscale score on NRS ranged from 0 (no pain) to 10 (extreme pain), where higher scores indicated higher pain. Change from baseline was calculated using the difference between post-baseline weekly mean and the baseline mean score. Participants may have been counted more than once if they had TJR surgery in more than one joint. | Baseline, Week 24 | |
Primary | Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Stiffness Subscale at Week 24 | WOMAC: self-administered, disease-specific questionnaire, which assesses clinically important, participant-relevant symptoms for pain, stiffness and physical function in participants with OA. Stiffness was defined as a sensation of decreased ease of movement in the index joint (knee or hip). The WOMAC stiffness subscale is a 2-item questionnaire used to assess the amount of stiffness experienced due to OA in the replaced/to be replaced index joint (knee or hip) during the past 48 hours. It was calculated as the mean of scores from 2 individual questions scored on NRS. Scores for each question and WOMAC stiffness subscale score on NRS ranged from 0 (no stiffness) to 10 (extreme stiffness), where higher scores indicated higher stiffness. Change from baseline was calculated using the difference between post-baseline weekly mean and the baseline mean score. Participants may have been counted more than once if they had TJR surgery in more than one joint. | Baseline, Week 24 | |
Primary | Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Physical Function Subscale at Week 24 | WOMAC: Self-administered, disease-specific questionnaire, which assesses clinically important, participant-relevant symptoms for pain, stiffness and physical function in participants with OA. Physical function refers to participant's ability to move around and perform usual activities of daily living. The WOMAC physical function subscale is a 17-item questionnaire used to assess the degree of difficulty experienced due to OA in replaced/ to be replaced index joint (knee or hip) during past 48 hours. It was calculated as mean of the scores from 17 individual questions, which may not be a whole (integer) number, scored on a NRS. Scores for each question and WOMAC physical function subscale score on NRS ranged from 0 (no difficulty) to 10 (extreme difficulty), where higher scores indicated extreme difficulty/worse physical function. Participants may have been counted more than once if they had TJR surgery in more than one joint. | Baseline, Week 24 | |
Primary | Change From Baseline in Shoulder Pain and Disability Index (SPADI) Score at Week 24 | SPADI: self-administered questionnaire to measure pain and disability associated with shoulder pathology in participants with shoulder pain. It consists of two dimensions pain and function. Pain dimension:5 questions regarding severity of pain, scores ranged from 0=no pain to 10=worst pain imaginable, higher scores indicated extreme pain. Functional activities:8 questions to measure degree of difficulty with various activities of daily living that require upper extremity use, scores ranged from 0=no difficulty to 10=so difficult it requires help, higher scores=extreme difficulty. Pain and disability dimension score was calculated as the sum of non-missing scores divided by the maximum possible score (50 [for pain] and 80 [for disability]) multiplied by 100. A total score was calculated as the mean of two dimensions, ranged from 0=best to 100=worst, higher scores indicated worsening of condition. | Baseline, Week 24 | |
Primary | Number of Participants Who Used Concomitant Analgesic Medications | Baseline up to Week 24 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04657926 -
A Trial of APPA in the Treatment of Knee Osteoarthritis
|
Phase 2 | |
Completed |
NCT02536833 -
A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
|
Phase 2 | |
Completed |
NCT03014037 -
Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration
|
N/A | |
Recruiting |
NCT05937542 -
A Qualitative Investigation of CLEAT Participants
|
||
Completed |
NCT03644615 -
A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT06061367 -
Muscles Strength and Gait Parameteres After TKA
|
||
Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03850665 -
Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach
|
N/A | |
Completed |
NCT02826902 -
Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial
|
N/A | |
Completed |
NCT04402502 -
Dynamic 4DCT to Examine Wrist Carpal Mechanics
|
N/A | |
Completed |
NCT02923700 -
Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial
|
Phase 4 | |
Completed |
NCT04564053 -
Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants
|
Phase 1 | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Not yet recruiting |
NCT05036174 -
Diphenhydramine Ointment for Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT02912429 -
Onlay vs. Inlay Patellofemoral Arthroplasty
|
N/A | |
Recruiting |
NCT02666443 -
Low Dose Dexamethasone in Supraclavicular Blocks
|
N/A | |
Active, not recruiting |
NCT02723929 -
Effects of tDCS and tUS on Pain Perception in OA of the Knee
|
||
Terminated |
NCT02820766 -
Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting
|
N/A | |
Withdrawn |
NCT02921594 -
Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties
|
N/A |